General Information of the Compound
Compound ID
CP0138007
Compound Name
N-(3,4-dihydro-2H-chromen-2-ylmethyl)-N'-(1,3-thiazol-2-yl)propane-1,3-diamine
    Show/Hide
Structure
Formula
C16H21N3OS
Molecular Weight
303.431
Canonical SMILES
C(CNCC1CCc2ccccc2O1)CNc1nccs1
    Show/Hide
InChI
InChI=1S/C16H21N3OS/c1-2-5-15-13(4-1)6-7-14(20-15)12-17-8-3-9-18-16-19-10-11-21-16/h1-2,4-5,10-11,14,17H,3,6-9,12H2,(H,18,19)
    Show/Hide
InChIKey
MJWMXSYGNBDXJZ-UHFFFAOYSA-N
Physicochemical Property
logP
2.9285
Rotatable Bonds
7
Heavy Atom Count
21
Polar Areas
46.18
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
5
Complexity
21

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44322886
ChEMBL ID
CHEMBL89427
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000803 HA7 Homo sapiens (Human)  1
1
IC50 = 1.585 nM
   TI
   LI
   LO
   TS